Read Our Articles
Glutathione Supplements: Benefits, Absorption, and Whether They Actually Work
Antioxidants & Healthy Aging Glutathione Supplements: Benefits, Absorption, and Whether They Actually Work Glutathione is one of the body’s most important antioxidants, but that does not automatically mean taking glutathione capsules produces major health benefits. Your cells already manufacture glutathione
Akkermansia Supplement: Benefits, Weight Loss, Gut Health, and Side Effects
Gut Microbiome & Metabolic Health Akkermansia Supplement: Benefits, Weight Loss, Gut Health, and Side Effects Akkermansia supplements have become one of the more interesting developments in the microbiome space because Akkermansia muciniphila is not a typical probiotic. It naturally lives
Foundayo vs Wegovy Pill: Weight Loss, Side Effects, Cost, and Dosing
Oral GLP-1 Weight-Loss Comparison Foundayo vs Wegovy Pill: Weight Loss, Side Effects, Cost, and Dosing Foundayo and the Wegovy pill are FDA-approved once-daily oral GLP-1 medications for chronic weight management, but they use different drugs and have important practical differences.
Orforglipron vs Rybelsus: How Lilly’s Oral GLP-1 Pill Compares
Oral GLP-1 Comparison Orforglipron vs Rybelsus: How Lilly’s Oral GLP-1 Pill Compares Orforglipron and Rybelsus are both once-daily oral GLP-1 receptor agonists, but they are not the same type of drug or used in the same way. Orforglipron is Lilly’s
Orforglipron for Weight Loss: Results, Side Effects, and Current Status
Oral GLP-1 Weight-Loss Medication Orforglipron for Weight Loss: Results, Side Effects, and Current Status Orforglipron is an oral GLP-1 receptor agonist approved by the FDA under the brand name Foundayo for chronic weight management in adults with obesity, or adults
Ribupatide for Weight Loss: Oral and Injectable GLP-1/GIP Results
Investigational Weight-Loss Drugs Ribupatide for Weight Loss: Oral and Injectable GLP-1/GIP Results Ribupatide is an investigational dual GLP-1/GIP receptor agonist being developed in both once-weekly injectable and once-daily oral forms for obesity and overweight. The injectable version is further along
Is Retatrutide Approved Yet? FDA Status, Availability, and Timeline
FDA Status & Drug Availability Is Retatrutide Approved Yet? FDA Status, Availability, and Timeline No. As of May 19, 2026, retatrutide is not FDA-approved for weight loss, type 2 diabetes, or any other condition. It remains an investigational once-weekly triple
CT-388 for Weight Loss: Results, Side Effects, and Current Status
Investigational Weight-Loss Drugs CT-388 for Weight Loss: Results, Side Effects, and Current Status CT-388, also called enicepatide, is an investigational once-weekly injectable GLP-1/GIP receptor agonist being developed by Roche and Genentech for obesity, type 2 diabetes, and related metabolic conditions.
GHK-Cu Copper Peptide: Benefits, Science, and Best Skincare Serums
Skin Peptides & Cosmetic Actives GHK-Cu Copper Peptide: The Complete 2026 Guide to Benefits, Science & Best Skincare Serums GHK-Cu, also called copper tripeptide-1, is a copper-binding peptide used in skincare for firmness, texture, fine lines, and skin repair support.
CT-388 vs Tirzepatide: How Roche’s GLP-1/GIP Drug Compares
Drug Comparison CT-388 vs Tirzepatide: How Roche’s GLP-1/GIP Drug Compares CT-388 and tirzepatide are both once-weekly injectable GLP-1/GIP receptor agonists, but they are not at the same evidence stage. Tirzepatide is FDA-approved for chronic weight management under the Zepbound brand,
VK2735 for Weight Loss: Oral GLP-1/GIP Results and Current Status
Investigational Weight-Loss Drugs VK2735 for Weight Loss: Oral GLP-1/GIP Results and Current Status VK2735 is an investigational dual GLP-1/GIP receptor agonist being studied for weight loss in both oral and injectable forms. The oral tablet has shown meaningful short-term weight
MariTide for Weight Loss: Monthly Injection, Results, and Current Status
Investigational monthly weight-loss injection guide By VerifiedSupps Editorial Team MariTide for Weight Loss: Monthly Injection, Results, and Current Status MariTide is an investigational long-acting weight-loss medication designed for monthly or less frequent injection. In Phase 2, it produced substantial weight